These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3492275)

  • 21. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effective mechanisms of BRM, with special reference to induction of autologous tumor cell-killing (ATK) activity by OK-432].
    Hoshino T; Uchida A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1277-84. PubMed ID: 3488024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells.
    Bonavida B; Wright SC
    J Clin Immunol; 1986 Jan; 6(1):1-8. PubMed ID: 3958135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction by OK-432 of the monolayer contact-mediated inhibition of human natural killer cell activity.
    Yagita M; Saksela E
    Immunol Lett; 1990 Sep; 25(4):347-53. PubMed ID: 2249878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. YAC-1 variant clones selected for resistance to natural killer cytotoxic factors are also resistant to natural killer cell-mediated cytotoxicity.
    Wright SC; Bonavida B
    Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1688-92. PubMed ID: 6572932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro augmentation of human natural killer (NK) cell activity by a streptococcal preparation OK-432 and its extracts, protein M and polysaccharides.
    Wakasugi H; Oshimi K; Kasahara T; Miyata M; Morioka Y
    Int Arch Allergy Appl Immunol; 1982; 67(4):322-8. PubMed ID: 7040254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between radical production and natural killer cytotoxic factor (NKCF) in canine natural killer (NK) cell-mediated cytotoxicity.
    Nakada Y; Tsukatani Y; Kosaka T; Kuwabara M; Tanaka S; Fujiwara K
    Vet Immunol Immunopathol; 1997 Mar; 55(4):273-82. PubMed ID: 9151399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of natural killer cytotoxic factor (NKCF) from canine NK cells.
    Nakada Y; Soga M; Kosaka T; Tsukatani Y; Miyamori M; Kuwabara M; Tanaka S; Koide F; Fujiwara K
    Vet Immunol Immunopathol; 1996 Jan; 49(4):283-93. PubMed ID: 8677631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432.
    Christmas SE; Meager A; Moore M
    Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OK-432 stimulates primary production and activity of murine natural killer cells.
    Pollack SB
    Nat Immun Cell Growth Regul; 1987; 6(5):224-36. PubMed ID: 3444437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K; Kuribayashi K; Saito K
    Cancer Immunol Immunother; 1989; 29(2):79-86. PubMed ID: 2497980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced generation of OK-432-induced killer cells by interleukin 2.
    Ujiie T
    Jpn J Exp Med; 1987 Jun; 57(3):183-8. PubMed ID: 3500332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E; Targan SR
    J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells.
    Blanca I; Herberman RB; Ortaldo JR
    Nat Immun Cell Growth Regul; 1985; 4(1):48-59. PubMed ID: 4033671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.
    Wakasugi H; Oshimi K; Miyata M; Morioka Y
    J Clin Immunol; 1981 Jul; 1(3):154-62. PubMed ID: 6174541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors.
    Wright SC; Wilbur SM; Bonavida B
    Nat Immun Cell Growth Regul; 1985; 4(4):202-20. PubMed ID: 2999581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates.
    Nair MP; Schwartz SA; Menon M
    Cell Immunol; 1985 Aug; 94(1):159-71. PubMed ID: 3926326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF.
    Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW
    J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of interleukin-2, OK-432 and interferon-gamma on in vitro induction of nonspecific killer cells by concanavalin A in mice.
    Mizushima Y; Iwata M; Sato M; Yano S
    Tohoku J Exp Med; 1986 Jan; 148(1):79-85. PubMed ID: 3085284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.